Polkadotedge
2025-11-15
Merck is dropping $9.2 billion on Cidara Therapeutics, primarily for CD388, a flu antiviral. That's a hefty price tag, even for a company of Merck's size. The question, as always,...
Polkadotedge
2025-11-14
Cidara's $9.2 Billion Buyout: Proof That Biotech's Boldest Bets Pay Off Big Okay, everyone, buckle up because this is exactly the kind of news that gets me absolutely buzzing about...
